2017 Volume 39 Issue 6 Pages 456-459
Non-Vitamin K antagonist oral anticoagulants (NOACs) are fewer bleeding complication agents than Warfarin. So NOACs become widely used, but there has no established treatment guidelines for intracranial bleeding patients taking NOACs. We experienced a patient with traumatic acute subdural hematoma who had taken dabigatran etexilate and received craniotomy for the removal of hematoma with the administration of frozen fresh plasma (FFP). An 87-year-old woman was ambulanced to our ER for head injury. She had taken dabigatran etexilate 110 mg 6 hours before head injury and CT scans showed left traumatic acute subdural hematoma. Because her conscious was alert, and she did not have any neurological deficit, we treated conservatively. But 3 hours later after head injury, she developed coma and CT scans showed that the acute subdural hematoma was enlarged. So we performed a craniotomy for the removal of the hematoma with the administration of frozen fresh plasma. Bleeding tendency was not observed during the surgery. Her postoperative course was good and transferred to other nursing facility.
